LGBI yields 20000000.00% · PFE yields 6.13%● Live data
📍 LGBI pulled ahead of the other in Year 1
Combined, LGBI + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of LGBI + PFE for your $10,000?
Cannabiz Mobile, Inc. operates as a mobile media and marketing company for businesses in the medical marijuana industry primarily in the United States and Canada. The company markets a subscription based, in the cloud, mobile media solution that enables care givers, dispensaries, hydroponic, and ancillary product retailers to create, deploy, and analytically measure mobile marketing campaigns using various networks and devices. It also enables businesses to create customizable personal audio and video advertisements, commercials, podcasts, and presentations that are accessible through various smart phone devices; and designs generic action pages and custom mobile Websites in which the end user has the ability to save the Mobile APP to their home screen. In addition, the company provides suppliers with mobile solutions to facilitate them in running their business through the use of the company's mobile marketing software, including mobile coupons, birthday reminders, alerts mobile business cards, mobile sites, and apps. Its software also facilitates in keeping patients informed of new medicine, as well as uses SMS text as a way to communicate for appointment reminders, refills, etc.; and provides refill reminders. The company was formerly known as Lion Gold Brazil, Inc. and changed its name to Cannabiz Mobile, Inc. in June 2014. Cannabiz Mobile, Inc. is based in Cambridge, Massachusetts.
Full LGBI Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.